How is Rising Cancer Prevalence Helping Protein A Resin Market Growth?

By -

 Cancer kills over 9.5 million people each year, as per the World Health Organization (WHO), which makes it the second leading cause of human mortality. With the increasing prevalence of this disease in developed as well as developing countries, the pressure on the medical fraternity to find an effective treatment is increasing. Though there are numerous therapies available, such as surgery, radiation, chemotherapy, and targeted medication, cancer has a high chance of coming back. This is why extensive research is being put in by pharmaceutical and biotechnology companies.

Receive Sample Copy of this Report:https://www.psmarketresearch.com/market-analysis/protein-a-resin-market/report-sample

Two of the novel and most promising answers to cancer that such activities have yielded thus far are monoclonal antibodies (mAb) and proteins. To produce both these biopharmaceuticals, laboratories require something known as protein A resin. Thus, with the increasing focus on protein-based research, the protein A resin market, which valued $486.4 million in 2019, seems set on the path to reaching $1,020.7 million by 2030, at a 7.0% CAGR during 2019–2030. Originally found in the Staphylococcus aureus (S. aureus) bacteria, the protein is used to purify mAbs and commercially produce proteins via the method of immunoprecipitation.

Make an Enquiry before Purchase:https://www.psmarketresearch.com/send-enquiry?enquiry-url=protein-a-resin-market

Of the two main application of this product discussed above, antibody purification has accounted for its wider consumption, simply because mAbs are being used as therapy for a large number diseases. This is also why, among all the sectors which use protein A resin, viz. academic institutes and research laboratories and biotechnology and pharmaceutical industries, the latter use them more, to produce antibodies. Moreover, the use of this biological compound in research is also significant, especially with government agencies, such as the National Institutes of Health, heavily funding medical and life sciences research.

Comments

Post a Comment

Popular posts from this blog

How is Increasing Focus on Personalized Medicine Driving Cancer/Tumor Profiling Market?

By -
Image
Every year, over 9.5 million people die as result of cancer, as per the World Health Organization (WHO), thereby becoming one of the major reasons for human mortality around the world. The disease, which is most prominently characterized by the presence of tumors, forms when a mutation (undesirable change) in a gene or protein causes a particular type of cell to divide faster than the rate of the normal cell death, thereby resulting in the growth of a visible mass.  Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/cancer-profiling-market/report-sample This is concurrent with the fact that among the genomics, proteomics, metabolomics, and epigenetics techniques, genomics is the most widely used one. As the root cause of the cancer can be determined by studying which gene mutated and how, targeted therapies can be devised. Such analysis can also help ascertain if the patient would be at risk of a relapse. All these techniques and technologies find ...
Read more

What are Major Factors Driving Progress of Global Next-Generation Antibody Therapeutics Market?

By -
Image
 The increasing number of technological developments in the healthcare industry is one of the major factors fuelling the surge in the demand for next-generation antibody therapeutics solutions throughout the globe. For instance, there have been major developments in the healthcare technologies over the last few years such as the development of bispecific antibodies (BsAbs), ADC technologies, and glycoengineered antibody. These advancements have significantly increased the application area of the antibody therapeutics. The other major factor propelling the demand for next-generation antibody therapeutics solutions is the increasing prevalence of chronic diseases across the world. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/next-generation-antibody-market/report-sample ADCs are widely considered to be much safer and effective than the conventionally used antibodies for cancer treatment as these are made by combining a biologically active cytot...
Read more

How is Popularity of Personalize Medicine Helping Oligonucleotide Synthesis Market Advance?

By -
Image
Though there are a set number of health conditions that can affect people, the actual effect they have can vary from one individual to another. This is because, though similar, every human is slightly different on the genetic level. Consequently, one treatment that works for one patient has no guarantee of working for another. With the realization of this fact, the medical specialty of personalized medicine has emerged, wherein the genetics of a person are studied to devise a suitable treatment. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/oligonucleotide-synthesis-market/report-sample With extensive research and development (R&D), scientists have realized that a lot of diseases are caused by mutations in a particular gene, and if that particular gene is somehow deactivated, the disease could be managed. One of the ways it is being done is by artificially producing an antisense oligonucleotide, which is a single-strand deoxyribonucleic a...
Read more